Deals2 Sept 2026, 10:20 pm
RPG Life Sciences Subsidiary Acquires API Business for ₹135 Cr
AI Summary
RPG Life Sciences Ltd announced that its wholly-owned subsidiary, RPG Active Pharma Limited, will acquire the Active Pharmaceutical Ingredients (APIs) and intermediates business of Raghava Life Sciences Private Limited via a slump sale. The transaction, valued at up to ₹135 crores, includes manufacturing and R&D facilities, and a portfolio of 29 API molecules. This acquisition aligns with the company's strategy to expand its API business. The deal is expected to be completed within 30 days, subject to regulatory approvals.
Key Highlights
- Subsidiary RPG Active Pharma to acquire API business.
- Transaction valued at up to ₹135 crores via slump sale.
- Acquisition includes manufacturing, R&D facilities, and API portfolio.
- Deal supports RPG Life Sciences' API business expansion strategy.
- Transaction subject to regulatory approvals and expected within 30 days.
Price Impact
More from RPGLIFE